speb/financial-data huggingface dataset:
CME cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
CME cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CME cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -8200000.00
CME balance_sheet (quarterly, 2025-06-30) — Net Debt: 1439100000.00
CME income_statement (quarterly, 2025-06-30) — Net Income: 1025100000.00
CME income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1012200000.00
CME income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1025100000.00
CME income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1025100000.00
CME income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1025100000.00
CME cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1025100000.00
CME income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1025100000.00
CME income_statement (quarterly, 2025-06-30) — Net Interest Income: -44000000.00
CME cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 400000.00
CME cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CME cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CME income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -44000000.00
CME cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 21462700000.00
CME balance_sheet (quarterly, 2025-06-30) — Net PPE: 362900000.00
CME cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -18400000.00
CME balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -2688700000.00
CME balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5232600000.00
CME balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 5232600000.00
CME income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -60700000.00
CME income_statement (quarterly, 2025-06-30) — Normalized Income: -145586400.00
CME cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1058500000.00
CME cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CME income_statement (quarterly, 2025-06-30) — Operating Income: 1129300000.00
CME income_statement (quarterly, 2025-06-30) — Operating Revenue: 1586100000.00
CME balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 359650138.00
CME balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 519100000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 142702500000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 45400000.00
CME income_statement (quarterly, 2025-06-30) — Other Gand A: 37400000.00
CME income_statement (quarterly, 2025-06-30) — Other Income Expense: 245000000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 19903800000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3666300000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 720200000.00
CME income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1372400000.00
CME income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 220300000.00
CME balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 117600000.00
CME income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 7200000.00
CME balance_sheet (quarterly, 2025-06-30) — Payables: 92300000.00
CME balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 92300000.00
CME balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CME income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 5700000.00
CME income_statement (quarterly, 2025-06-30) — Pretax Income: 1330300000.00
CME cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CME cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -800000.00
CME cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -18400000.00
CME balance_sheet (quarterly, 2025-06-30) — Receivables: 667600000.00
CME income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 221600000.00
CME income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 83400000.00
CME cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
CME cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -8200000.00
CME balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 142164500000.00
CME balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 5254900000.00
CME cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1200000.00
CME income_statement (quarterly, 2025-06-30) — Selling General And Administration: 37400000.00
CME balance_sheet (quarterly, 2025-06-30) — Share Issued: 359650138.00
CME cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 20700000.00
CME balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 27739000000.00
CME balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -2688700000.00
CME income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 347713600.00
CME income_statement (quarterly, 2025-06-30) — Tax Provision: 305200000.00
CME income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
CME balance_sheet (quarterly, 2025-06-30) — Total Assets: 179907000000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 31159400000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Debt: 3420400000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 27739000000.00
CME income_statement (quarterly, 2025-06-30) — Total Expenses: 562700000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 152168000000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 34456900000.00
CME balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 9373200000.00
CME income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1129300000.00
CME income_statement (quarterly, 2025-06-30) — Total Unusual Items: 1518400000.00
CME income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 1518400000.00
CME balance_sheet (quarterly, 2025-06-30) — Working Capital: 2655300000.00
CME income_statement (quarterly, 2025-09-30) — +Operating Expense: 327400000.00
CME income_statement (quarterly, 2025-09-30) — +Total Revenue: 1537600000.00
CME balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 74900000.00
CME balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 642900000.00
CME balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -983200000.00
CME balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 22436900000.00
CME balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -9200000.00
CME income_statement (quarterly, 2025-09-30) — Amortization: 56200000.00
CME cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 56200000.00
CME cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 56200000.00
CME income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 56200000.00
CME income_statement (quarterly, 2025-09-30) — Basic Average Shares: 359686000.00
CME income_statement (quarterly, 2025-09-30) — Basic EPS: 2.49
CME cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 144145800000.00
CME cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -18400000.00
CME balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3600000.00
CME balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2446800000.00
CME balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2570000000.00
CME cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -455300000.00
CME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 6399700000.00
CME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -19100000.00
CME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 968100000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -17500000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -700000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 54300000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -75600000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Payable: -18200000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -18200000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Receivables: 25500000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -700000.00
CME cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -14000000.00
CME cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 25500000.00
CME cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7348700000.00
CME balance_sheet (quarterly, 2025-09-30) — Common Stock: 3600000.00
CME balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 28190300000.00
CME cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CME income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 237600000.00
CME balance_sheet (quarterly, 2025-09-30) — Current Assets: 152800800000.00
CME balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 149587200000.00
CME cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -6700000.00
CME cash_flow (quarterly, 2025-09-30) — Deferred Tax: -6700000.00
CME cash_flow (quarterly, 2025-09-30) — Depreciation: 26400000.00
CME cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 82600000.00
CME income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 82600000.00
CME cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 82600000.00
CME income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 82600000.00
CME income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 26400000.00
CME income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 360422000.00
CME income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.49
CME income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 896600000.00
CME income_statement (quarterly, 2025-09-30) — EBIT: 1221000000.00
CME income_statement (quarterly, 2025-09-30) — EBITDA: 1303600000.00
CME income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 96300000.00
CME cash_flow (quarterly, 2025-09-30) — End Cash Position: 151494500000.00
CME cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 6399700000.00
CME cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 949700000.00
CME cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -400000.00
CME income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1548700000.00
CME balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 43400000.00
CME income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 36700000.00
CME balance_sheet (quarterly, 2025-09-30) — Goodwill: 10514500000.00
CME balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 30357600000.00
CME balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 652100000.00
CME balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1338400000.00
CME income_statement (quarterly, 2025-09-30) — Gross Profit: 1300000000.00
CME cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 275600000.00
CME income_statement (quarterly, 2025-09-30) — Interest Expense: 44000000.00
CME income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44000000.00
CME cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 46700000.00
CME balance_sheet (quarterly, 2025-09-30) — Invested Capital: 31611600000.00
CME cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -19100000.00
CME cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -1700000.00
CME balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3421300000.00
CME balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3421300000.00
CME cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -1700000.00
CME cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
CME cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1000000.00
CME cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CME balance_sheet (quarterly, 2025-09-30) — Net Debt: 974500000.00
CME income_statement (quarterly, 2025-09-30) — Net Income: 908000000.00
CME income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 896600000.00
CME income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 908000000.00
CME income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 908000000.00
CME income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 908000000.00
CME cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 908000000.00
CME income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 908000000.00
CME income_statement (quarterly, 2025-09-30) — Net Interest Income: -44000000.00
CME cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 300000.00
CME cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1700000.00
CME cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1700000.00
CME income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -44000000.00
CME cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 6856700000.00
CME balance_sheet (quarterly, 2025-09-30) — Net PPE: 355200000.00
CME cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -18400000.00
CME balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -2167300000.00
CME balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 5220100000.00
CME balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 5220100000.00
CME income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -245100000.00
CME income_statement (quarterly, 2025-09-30) — Normalized Income: -286047700.00
CME cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 968100000.00
CME cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -400000.00
CME income_statement (quarterly, 2025-09-30) — Operating Income: 972600000.00
CME income_statement (quarterly, 2025-09-30) — Operating Revenue: 1430400000.00
CME balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 359852138.00
CME balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 540200000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 149512300000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 43400000.00
CME income_statement (quarterly, 2025-09-30) — Other Gand A: 36700000.00
CME income_statement (quarterly, 2025-09-30) — Other Income Expense: 248400000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 19843100000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3631000000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 725700000.00
CME income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1396600000.00
CME income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 208100000.00
CME balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 123200000.00
CME income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 5700000.00
CME balance_sheet (quarterly, 2025-09-30) — Payables: 74900000.00
CME balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 74900000.00
CME balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CME income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 5700000.00
CME income_statement (quarterly, 2025-09-30) — Pretax Income: 1177000000.00
CME cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1000000.00
CME cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1100000.00
CME cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -18400000.00
CME balance_sheet (quarterly, 2025-09-30) — Receivables: 642900000.00
CME income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 237600000.00
CME income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 82600000.00
CME cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
CME cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CME balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 149047700000.00
CME balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 5706400000.00
CME cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1400000.00
CME income_statement (quarterly, 2025-09-30) — Selling General And Administration: 36700000.00
CME balance_sheet (quarterly, 2025-09-30) — Share Issued: 359852138.00
CME cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 24000000.00
CME balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 28190300000.00
CME balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -2167300000.00
CME income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 354652300.00
CME income_statement (quarterly, 2025-09-30) — Tax Provision: 269000000.00
CME income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
CME balance_sheet (quarterly, 2025-09-30) — Total Assets: 187144600000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 31611600000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Debt: 3421300000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 28190300000.00
CME income_statement (quarterly, 2025-09-30) — Total Expenses: 565000000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 158954300000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 34343800000.00
CME balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9367100000.00
CME income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 972600000.00
CME income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1548700000.00
CME income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1548700000.00
CME balance_sheet (quarterly, 2025-09-30) — Working Capital: 3213600000.00
CME income_statement (annual, 2025-12-31) — +Operating Expense: 1384100000.00
CME income_statement (quarterly, 2025-12-31) — +Operating Expense: 388000000.00
CME income_statement (annual, 2025-12-31) — +Total Revenue: 6520600000.00
CME income_statement (quarterly, 2025-12-31) — +Total Revenue: 1648700000.00
CME balance_sheet (annual, 2025-12-31) — Accounts Payable: 71800000.00
CME balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 71800000.00
CME balance_sheet (annual, 2025-12-31) — Accounts Receivable: 639200000.00
CME balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 639200000.00
CME balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1005700000.00
CME balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1005700000.00
CME balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 22209500000.00
CME balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 22209500000.00
CME balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -10000000.00
CME balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -10000000.00
CME income_statement (annual, 2025-12-31) — Amortization: 223400000.00
CME income_statement (quarterly, 2025-12-31) — Amortization: 55900000.00
CME cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 223400000.00
CME cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 55900000.00
CME cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 223400000.00
CME cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 55900000.00
CME income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 223400000.00
CME income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 55900000.00
CME income_statement (annual, 2025-12-31) — Basic Average Shares: 359648000.00
CME income_statement (quarterly, 2025-12-31) — Basic Average Shares: 359633000.00
CME income_statement (annual, 2025-12-31) — Basic EPS: 11.18
CME income_statement (quarterly, 2025-12-31) — Basic EPS: 3.25
CME cash_flow (annual, 2025-12-31) — Beginning Cash Position: 101794100000.00
CME cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 151494500000.00
CME balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 130700000.00
CME balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 130700000.00
CME cash_flow (annual, 2025-12-31) — Capital Expenditure: -83500000.00
CME cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -32500000.00
CME balance_sheet (annual, 2025-12-31) — Capital Stock: 3600000.00
CME balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3600000.00
CME balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4416900000.00
CME balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4416900000.00
CME balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4541900000.00
CME balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4541900000.00
CME cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -3933000000.00
CME cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -455000000.00
CME cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 56509500000.00
CME cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9899200000.00
CME cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1498800000.00
CME cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1551900000.00
CME cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4277100000.00
CME cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1133900000.00
CME cash_flow (annual, 2025-12-31) — Change In Account Payable: -8100000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -3100000.00
CME cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 91100000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 63500000.00
CME cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 31800000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -27700000.00
CME cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 52000000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 68900000.00
CME cash_flow (annual, 2025-12-31) — Change In Payable: 83000000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Payable: 60400000.00
CME cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 83000000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 60400000.00
CME cash_flow (annual, 2025-12-31) — Change In Receivables: -67100000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2800000.00
CME cash_flow (annual, 2025-12-31) — Change In Tax Payable: 91100000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 63500000.00
CME cash_flow (annual, 2025-12-31) — Change In Working Capital: 99700000.00
CME cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 104400000.00
CME cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -67100000.00
CME cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 2800000.00
CME cash_flow (annual, 2025-12-31) — Changes In Cash: 62285400000.00
CME cash_flow (quarterly, 2025-12-31) — Changes In Cash: 12585000000.00
CME balance_sheet (annual, 2025-12-31) — Common Stock: 3600000.00
CME balance_sheet (quarterly, 2025-12-31) — Common Stock: 3600000.00
CME balance_sheet (annual, 2025-12-31) — Common Stock Equity: 28728200000.00
CME balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 28728200000.00
CME cash_flow (annual, 2025-12-31) — Common Stock Payments: -266100000.00
CME cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -257900000.00
CME income_statement (annual, 2025-12-31) — Cost Of Revenue: 907000000.00
CME income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 241100000.00
CME balance_sheet (annual, 2025-12-31) — Current Assets: 165359300000.00
CME balance_sheet (quarterly, 2025-12-31) — Current Assets: 165359300000.00
CME balance_sheet (annual, 2025-12-31) — Current Liabilities: 160296700000.00
CME balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 160296700000.00
CME cash_flow (annual, 2025-12-31) — Deferred Income Tax: -6100000.00
CME cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 21300000.00
CME cash_flow (annual, 2025-12-31) — Deferred Tax: -6100000.00
CME cash_flow (quarterly, 2025-12-31) — Deferred Tax: 21300000.00
CME cash_flow (annual, 2025-12-31) — Depreciation: 107500000.00
CME cash_flow (quarterly, 2025-12-31) — Depreciation: 26500000.00
CME cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 330900000.00
CME cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 82400000.00
CME income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 330900000.00
CME income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 82400000.00
CME cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 330900000.00
CME cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 82400000.00
CME income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 330900000.00
CME income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 82400000.00
CME income_statement (annual, 2025-12-31) — Depreciation Income Statement: 107500000.00
CME income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 26500000.00
CME income_statement (annual, 2025-12-31) — Diluted Average Shares: 360310000.00
CME income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 360233000.00
CME income_statement (annual, 2025-12-31) — Diluted EPS: 11.16
CME income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.24
CME income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4021000000.00
CME income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1168000000.00
CME income_statement (annual, 2025-12-31) — EBIT: 5503900000.00
CME income_statement (quarterly, 2025-12-31) — EBIT: 1622100000.00
CME income_statement (annual, 2025-12-31) — EBITDA: 5834800000.00
CME income_statement (quarterly, 2025-12-31) — EBITDA: 1704500000.00
CME income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 371700000.00
CME income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 88200000.00
CME cash_flow (annual, 2025-12-31) — End Cash Position: 164079500000.00
CME cash_flow (quarterly, 2025-12-31) — End Cash Position: 164079500000.00
CME cash_flow (annual, 2025-12-31) — Financing Cash Flow: 56509500000.00
CME cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 9899200000.00
CME cash_flow (annual, 2025-12-31) — Free Cash Flow: 4193600000.00
CME cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1101400000.00
CME cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -352800000.00
CME cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -349800000.00
CME income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5736500000.00
CME income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1776700000.00
CME balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 81900000.00
CME balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 81900000.00
CME income_statement (annual, 2025-12-31) — General And Administrative Expense: 150500000.00
CME income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 47900000.00
CME balance_sheet (annual, 2025-12-31) — Goodwill: 10514700000.00
CME balance_sheet (quarterly, 2025-12-31) — Goodwill: 10514700000.00
CME balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 30300700000.00
CME balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 30300700000.00
CME balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 649200000.00
CME balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 649200000.00
CME balance_sheet (annual, 2025-12-31) — Gross PPE: 1368400000.00
CME balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1368400000.00
CME income_statement (annual, 2025-12-31) — Gross Profit: 5613600000.00
CME income_statement (quarterly, 2025-12-31) — Gross Profit: 1407600000.00
CME cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1164000000.00
CME cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 308800000.00
CME income_statement (annual, 2025-12-31) — Interest Expense: 173400000.00
CME income_statement (quarterly, 2025-12-31) — Interest Expense: 43700000.00
CME income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 173400000.00
CME income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 43700000.00
CME cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 135600000.00
CME cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 23900000.00
CME balance_sheet (annual, 2025-12-31) — Invested Capital: 32150500000.00
CME balance_sheet (quarterly, 2025-12-31) — Invested Capital: 32150500000.00
CME cash_flow (annual, 2025-12-31) — Investing Cash Flow: 1498800000.00
CME cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1551900000.00
CME cash_flow (annual, 2025-12-31) — Issuance Of Debt: 740600000.00
CME cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CME balance_sheet (annual, 2025-12-31) — Leases: 149500000.00
CME balance_sheet (quarterly, 2025-12-31) — Leases: 149500000.00
CME balance_sheet (annual, 2025-12-31) — Long Term Debt: 3422300000.00
CME balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3422300000.00
CME balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3422300000.00
CME balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3422300000.00
CME cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 740600000.00
CME cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CME cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -750000000.00
CME cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
CME balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1088200000.00
CME balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1088200000.00
CME cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 1580400000.00
CME cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 1583800000.00
CME cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -266100000.00
CME cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -257900000.00
CME income_statement (annual, 2025-12-31) — Net Income: 4072200000.00
CME income_statement (quarterly, 2025-12-31) — Net Income: 1182900000.00
CME income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4021000000.00
CME income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1168000000.00
CME income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4072200000.00
CME income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1182900000.00
CME income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4072200000.00
CME income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1182900000.00
CME income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4072200000.00
CME income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1182900000.00
CME cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4072200000.00
CME cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1182900000.00
CME income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4072200000.00
CME income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1182900000.00
CME income_statement (annual, 2025-12-31) — Net Interest Income: -173400000.00
CME income_statement (quarterly, 2025-12-31) — Net Interest Income: -43700000.00
CME cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1900000.00
CME cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 600000.00
CME cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -9400000.00
CME cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CME cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -9400000.00
CME cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CME income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -173400000.00
CME income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -43700000.00
CME cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 60718000000.00
CME cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 10612100000.00
CME balance_sheet (annual, 2025-12-31) — Net PPE: 362700000.00
CME balance_sheet (quarterly, 2025-12-31) — Net PPE: 362700000.00
CME cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -83500000.00
CME cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -32500000.00
CME balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1572500000.00
CME balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1572500000.00
CME balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 5242200000.00
CME balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5242200000.00
CME balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5242200000.00
CME balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5242200000.00
CME income_statement (annual, 2025-12-31) — Normalized EBITDA: 98300000.00
CME income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -72200000.00
CME income_statement (annual, 2025-12-31) — Normalized Income: -310486000.00
CME income_statement (quarterly, 2025-12-31) — Normalized Income: -148611929.80
CME cash_flow (annual, 2025-12-31) — Operating Cash Flow: 4277100000.00
CME cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1133900000.00
CME cash_flow (annual, 2025-12-31) — Operating Gains Losses: -352800000.00
CME cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -349800000.00
CME income_statement (annual, 2025-12-31) — Operating Income: 4229500000.00
CME income_statement (quarterly, 2025-12-31) — Operating Income: 1019600000.00
CME income_statement (annual, 2025-12-31) — Operating Revenue: 6084200000.00
CME income_statement (quarterly, 2025-12-31) — Operating Revenue: 1535900000.00
CME balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 358953138.00
CME balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 358953138.00
CME balance_sheet (annual, 2025-12-31) — Other Current Assets: 515600000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 515600000.00
CME balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 160224900000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 160224900000.00
CME balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 81900000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 81900000.00
CME income_statement (annual, 2025-12-31) — Other Gand A: 150500000.00
CME income_statement (quarterly, 2025-12-31) — Other Gand A: 47900000.00
CME income_statement (annual, 2025-12-31) — Other Income Expense: 1274400000.00
CME income_statement (quarterly, 2025-12-31) — Other Income Expense: 602500000.00
CME balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 19786000000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 19786000000.00
CME cash_flow (annual, 2025-12-31) — Other Non Cash Items: 38400000.00
CME cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 63800000.00
CME balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2401500000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2401500000.00
CME balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 734800000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 734800000.00
CME income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -4833800000.00
CME income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1262400000.00
CME income_statement (annual, 2025-12-31) — Other Operating Expenses: 902700000.00
CME income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 257700000.00
CME balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 125000000.00
CME balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 125000000.00
CME income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 28300000.00
CME income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 9200000.00
CME balance_sheet (annual, 2025-12-31) — Payables: 71800000.00
CME balance_sheet (quarterly, 2025-12-31) — Payables: 71800000.00
CME balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 71800000.00
CME balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 71800000.00
CME balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CME balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CME income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 22900000.00
CME income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 5700000.00
CME income_statement (annual, 2025-12-31) — Pretax Income: 5330500000.00
CME income_statement (quarterly, 2025-12-31) — Pretax Income: 1578400000.00
CME balance_sheet (annual, 2025-12-31) — Properties: 0.00
CME balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CME cash_flow (annual, 2025-12-31) — Purchase Of Business: -11000000.00
CME cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -7600000.00
CME cash_flow (annual, 2025-12-31) — Purchase Of Investment: -6000000.00
CME cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -1100000.00
CME cash_flow (annual, 2025-12-31) — Purchase Of PPE: -83500000.00
CME cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -32500000.00
CME balance_sheet (annual, 2025-12-31) — Receivables: 639200000.00
CME balance_sheet (quarterly, 2025-12-31) — Receivables: 639200000.00
CME income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 907000000.00
CME income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 241100000.00
CME income_statement (annual, 2025-12-31) — Reconciled Depreciation: 330900000.00
CME income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 82400000.00
CME cash_flow (annual, 2025-12-31) — Repayment Of Debt: -750000000.00
CME cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
CME cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -266100000.00
CME cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -257900000.00
CME balance_sheet (annual, 2025-12-31) — Restricted Cash: 159662600000.00
CME balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 159662600000.00
CME balance_sheet (annual, 2025-12-31) — Retained Earnings: 6433200000.00
CME balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 6433200000.00
CME cash_flow (annual, 2025-12-31) — Sale Of Business: 1591400000.00
CME cash_flow (annual, 2025-12-31) — Sale Of Investment: 7900000.00
CME cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1700000.00
CME income_statement (annual, 2025-12-31) — Selling General And Administration: 150500000.00
CME income_statement (quarterly, 2025-12-31) — Selling General And Administration: 47900000.00
CME balance_sheet (annual, 2025-12-31) — Share Issued: 358953138.00
CME balance_sheet (quarterly, 2025-12-31) — Share Issued: 358953138.00
CME cash_flow (annual, 2025-12-31) — Stock Based Compensation: 94800000.00
CME cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 28900000.00
CME balance_sheet (annual, 2025-12-31) — Stockholders Equity: 28728200000.00
CME balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 28728200000.00
CME balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1572500000.00
CME balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1572500000.00
CME income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1353814000.00
CME income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 445188070.20
CME income_statement (annual, 2025-12-31) — Tax Provision: 1258300000.00
CME income_statement (quarterly, 2025-12-31) — Tax Provision: 395500000.00
CME income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CME income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CME balance_sheet (annual, 2025-12-31) — Total Assets: 198424200000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Assets: 198424200000.00
CME balance_sheet (annual, 2025-12-31) — Total Capitalization: 32150500000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 32150500000.00
CME balance_sheet (annual, 2025-12-31) — Total Debt: 3422300000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Debt: 3422300000.00
CME balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 28728200000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 28728200000.00
CME income_statement (annual, 2025-12-31) — Total Expenses: 2291100000.00
CME income_statement (quarterly, 2025-12-31) — Total Expenses: 629100000.00
CME balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 169696000000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 169696000000.00
CME balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 33064900000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 33064900000.00
CME balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9399300000.00
CME balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9399300000.00
CME income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 4229500000.00
CME income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 1019600000.00
CME income_statement (annual, 2025-12-31) — Total Unusual Items: 5736500000.00
CME income_statement (quarterly, 2025-12-31) — Total Unusual Items: 1776700000.00
CME income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5736500000.00
CME income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1776700000.00
CME balance_sheet (annual, 2025-12-31) — Working Capital: 5062600000.00
CME balance_sheet (quarterly, 2025-12-31) — Working Capital: 5062600000.00
CME income_statement (quarterly, 2026-03-31) — +Operating Expense: 347400000.00
CME income_statement (quarterly, 2026-03-31) — +Total Revenue: 1880100000.00
CME balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 75400000.00
CME balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 935500000.00
CME balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1028300000.00
CME balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 21670600000.00
CME balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -9500000.00
CME income_statement (quarterly, 2026-03-31) — Amortization: 56100000.00
CME cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 56100000.00
CME cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 56100000.00
CME income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 56100000.00
CME income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: -13700000.00
CME income_statement (quarterly, 2026-03-31) — Basic Average Shares: 359318000.00
CME income_statement (quarterly, 2026-03-31) — Basic EPS: 3.25
CME cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 164079500000.00
CME cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -21800000.00
CME balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3600000.00
CME balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2391200000.00
CME balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2515400000.00
CME cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2697600000.00
CME cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2116500000.00
CME cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -23000000.00
CME cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1259900000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 3600000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 327600000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -46600000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 13300000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Payable: 331200000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 331200000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Receivables: -295800000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 327600000.00
CME cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2100000.00
CME cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -295800000.00
CME cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3353400000.00
CME balance_sheet (quarterly, 2026-03-31) — Common Stock: 3600000.00
CME cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2697600000.00
CME balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 26618200000.00
CME cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -538700000.00
CME income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 223000000.00
CME balance_sheet (quarterly, 2026-03-31) — Current Assets: 169001200000.00
CME balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 165997800000.00
CME cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -13400000.00
CME cash_flow (quarterly, 2026-03-31) — Deferred Tax: -13400000.00
CME cash_flow (quarterly, 2026-03-31) — Depreciation: 27200000.00
CME cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 83300000.00
CME income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 83300000.00
CME cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 83300000.00
CME income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 83300000.00
CME income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 27200000.00
CME income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 363208000.00
CME income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.18
CME income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1154300000.00
CME income_statement (quarterly, 2026-03-31) — EBIT: 1554500000.00
CME income_statement (quarterly, 2026-03-31) — EBITDA: 1637800000.00
CME income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 102400000.00
CME cash_flow (quarterly, 2026-03-31) — End Cash Position: 167432900000.00
CME cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2116500000.00